NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Lumexa Imaging Holdings, Inc. (LMRI) Stock Analysis

Lumexa Imaging Holdings, Inc. (LMRI) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

LMRI

$12.18

+$0.28 (+2.35%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LMRI with… →

LMRI Key Statistics

As of Sep 4, 2026
Trading
Open
$11.86
Previous Close
$11.90
Day's Range
11.71–12.32
52-Week Range
6.45–19.45
Volume
250.70K
Valuation
Market Cap
$1.17B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
13.38
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.12
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.29
Financials (FY)
Revenue (FY)
$1.02B+7.82%
Net Income (FY)
−$47.10M
Profit marginThe share of revenue left as profit after all costs and taxes.
−2.66%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
96.07M
Dividend and dates
Earnings Date
November 12, 2026
Avg Volume
572.48K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

LMRI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−34.16%
2025 (partial year)−0.11%

As of September 4, 2026.

LMRI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.02B−$47.10M−4.6%
2024$948.87M−$94.10M−9.9%
2023$935.93M−$122.23M−13.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.02B$157.57M$26.73M−$47.10M−4.6%
2024$948.87M$96.26M−$16.26M−$94.10M−9.9%
2023$935.93M$98.97M−$12.83M−$122.23M−13.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

LMRI Valuation vs Medical Devices Median

Median of 151 stocks
MetricLMRIMedical Devices medianvs median
P/S ratio1.122.9862% below
Profit margin−2.66%−1.69%1.0 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Lumexa Imaging Holdings, Inc. (LMRI) at $1.17B. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 5,000.

The most recent close on file for LMRI is $12.18, dated September 4, 2026. That is +$0.28 (+2.35%) against the previous close. Over the past 52 weeks the price has ranged from $6.45 to $19.45. The latest close sits 88.84% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $1.02B. That is +7.82% against the prior fiscal year, when revenue was $948.87M. The same year closed with a net loss of $47.10M. The reported profit margin is −2.66%. That is 1 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −0.29.

Across the 3 fiscal years on file, revenue moves from $935.93M in 2023 to $1.02B in 2025. Of those 3 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. On forward earnings the ratio is 13.38. The price-to-sales ratio is 1.12. On price-to-sales that is 62.31% below the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The stored price history starts on December 11, 2025, and the total return since then is −34.23%.

Growth & Income

The record shows no dividend for LMRI.

So far in 2026 the price is −34.16%.

Peer Comparison

Lumexa Imaging Holdings, Inc. (LMRI) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Lumexa Imaging Holdings, Inc. LMRI $1.17B —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Lumexa Imaging Holdings, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Lumexa Imaging Holdings, Inc.

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

Visit website →